Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

615 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
COPD: treatments benefit patients.
Rennard SI. Rennard SI. Lancet. 2003 Feb 8;361(9356):444-5. doi: 10.1016/S0140-6736(03)12467-1. Lancet. 2003. PMID: 12583937 No abstract available.
Pathogenesis of COPD.
Rennard SI. Rennard SI. Clin Cornerstone. 2003;5(1):11-6. doi: 10.1016/s1098-3597(03)90004-4. Clin Cornerstone. 2003. PMID: 12739307 Review.
Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.
Gamble E, Grootendorst DC, Brightling CE, Troy S, Qiu Y, Zhu J, Parker D, Matin D, Majumdar S, Vignola AM, Kroegel C, Morell F, Hansel TT, Rennard SI, Compton C, Amit O, Tat T, Edelson J, Pavord ID, Rabe KF, Barnes NC, Jeffery PK. Gamble E, et al. Among authors: rennard si. Am J Respir Crit Care Med. 2003 Oct 15;168(8):976-82. doi: 10.1164/rccm.200212-1490OC. Epub 2003 Jun 19. Am J Respir Crit Care Med. 2003. PMID: 12816740 Clinical Trial.
COPD: the dangerous underestimate of 15%.
Rennard SI, Vestbo J. Rennard SI, et al. Lancet. 2006 Apr 15;367(9518):1216-9. doi: 10.1016/S0140-6736(06)68516-4. Lancet. 2006. PMID: 16631861 No abstract available.
615 results